Results 161 to 170 of about 10,405 (214)

Clinical utility of sputum cytology in severe asthma: insights from a specialist centre. [PDF]

ERJ Open Res
Khan S, Gilbey S, Sheego M, Lyng E, Cass A, Latif S, Taylor R, Langman G, Shingler J, Stephens H, Pillai A, Mansur AH.   +11 more
europepmc   +1 more source

Biological treatments for asthma and chronic obstructive pulmonary disease. [PDF]

BMJ Med
Tejwani V, Siddharthan T, Majumdar U, Hatipoğlu U, Hanania NA.   +4 more
europepmc   +1 more source

Asthma diagnosis in school-age children: a survey among Swiss physicians

Guerra Buezo B, Sasaki M, Leuenberger LM, Glick S, Gaillard EA, Moeller A, Regamey N, Sutter O, Goutaki M, Kuehni CE.   +9 more
europepmc   +1 more source

Feno-klimatologisch onderzoek aan stamslabonen

, 1958
Post, J.J., Groenewegen, J.H.
openaire   +1 more source

Update on the Role of FeNO in Asthma Management

Diagnostics, 2023
Asthma is a heterogenous disorder characterized by presence of different phenotypes and endotypes. Up to 10% of the individuals suffer from severe asthma and are at increased risk of morbidity and mortality. Fractional exhaled nitric oxide (FeNO) is a cost-effective, point of care biomarker that is used to detect type 2 airway inflammation.
Muhammad Adrish, Nicola A Hanania, Damini Saxena   +2 more
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

FeNO in Asthma

Seminars in Respiratory and Critical Care Medicine, 2022
AbstractAsthma is a common disease affecting 350 million people worldwide, which is characterized by airways inflammation and hyperreactivity. Historically diagnosis and treatment have been mainly based on symptoms, which have the potential to result in misdiagnosis and inappropriate treatment.
Lola, Loewenthal, Andrew, Menzies-Gow
openaire   +2 more sources

A pathophysiological approach for FeNO: A biomarker for asthma

Allergologia Et Immunopathologia, 2015
The present review is focused on literature concerning the relevance of fractional exhaled nitric oxide (FeNO) in clinical practice from a pathophysiological point of view. There is increasing evidence that asthma is a heterogeneous pathological condition characterised by different phenotypes/endotypes related to specific biomarkers, including FeNO ...
Giorgio Ciprandi, Fabio Luigi Massimo Ricciardolo   +1 more
exaly   +3 more sources

FeNO as biomarker for asthma phenotyping and management

Allergy and Asthma Proceedings, 2015
The current review aims to revisit literature on exhaled nitric oxide (FeNO) in asthma phenotyping and management to clarify the utility of this test in clinical practice. It is increasingly evident that multiple profiles characterize asthma as a complex disease for which is necessary to find tools able to discriminate among these phenotypes to achieve
Giorgio Ciprandi, Fabio Luigi Massimo Ricciardolo   +1 more
exaly   +3 more sources

Correlation between the FeNO Angle and d−p Mixing in {FeNO}⁷ Complexes

Inorganic Chemistry, 2011
The great majority of low-spin {FeNO}(7) complexes exhibit FeNO angles of around 140-145°, whereas a small handful are characterized by linear FeNO units. Conspicuously absent are intermediate FeNO angles of 150-170°. Spurred by the recent observation of such an angle in a square-pyramidal {FeNO}(7) complex, we carried out a density functional theory ...
Jeanet, Conradie, Abhik, Ghosh
openaire   +2 more sources

Methacholine and FeNO Measurement in Patients with Habit Cough

Klinische Pädiatrie, 2023
Abstract Background Chronic cough is one of the most common symptoms in childhood. Making a definite diagnosis is a challenge for all pediatricians especially in patients when cough is without an organic cause like in habit cough.
Sandra Woelke, Alexandra Szelenyi, Melanie Dreßler, Jordis Trischler, Helena Donath, Martin Hutter, Katharina Blümchen, Stefan Zielen   +7 more
openaire   +2 more sources